HEMIFISTULARIN-3
Compound with spectra: 1 NMR
| SpectraBase Compound ID | HvqVvqJJ1gZ |
|---|---|
| InChI | InChI=1S/C18H16Br4N2O6/c1-29-15-10(21)4-18(16(27)13(15)22)5-11(24-30-18)17(28)23-6-12(25)7-2-8(19)14(26)9(20)3-7/h2-4,12,16,25-27H,5-6H2,1H3,(H,23,28)/t12?,16-,18+/m1/s1 |
| InChIKey | CEOWCDRCPWSIPW-YZCZPWFXSA-N |
| Mol Weight | 675.95 g/mol |
| Molecular Formula | C18H16Br4N2O6 |
| Exact Mass | 671.774188 g/mol |
| Enantiomer InChIKey | CEOWCDRCPWSIPW-IQHYPMEHSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
14-DEBROMOARAPLYSILLIN-1
PUREALIDIN-S
19-HYDROXYPSAMMAPLYSIN_X;ISOMER_1
1H-pyrazolo[3,4-b]pyridine, 4-(difluoromethyl)-6-(3,4-dimethoxyphenyl)-3-methyl-1-[(4-methylphenyl)methyl]-
(1S,3E,7R,11R,14S,17S,18R,19S)-7-(3-chloro-4-methoxy-benzyl)-18-hydroxy-14-isobutyl-11,19-dimethyl-17-phenyl-13,16-dioxa-6,9,20-triazabicyclo[13.4.1]eicosa-3,15(20)-diene-5,8,12-trione
(3'S,5'R)-1-{2'-DEOXY-5'-O-[(4,4'-DIMETHOXYTRIPHENYL)-METHYL]-3',5'-ETHANO-BETA-D-RIBOFURANOSYL}-THYMINE
(1RS,4SR,7SR,8RS,10SR)-2-aza-2,7-dimethyl-10-(2-methylpropyl)tricyclo[5.2.1.0(4,10)]decane-8-ol
(+/-)-(4R,5S)-2-METHYL-4-(1-METHYL-1H-PYRROL-2-YL)-7-PHENETHYL-2,7,9-TRIAZASPIRO-[4.5]-DECANE-6,8-DIONE
cis,trans-1-Methoxycarbonyl-2-phenyl-3-benzoyl-7,7-dimethyl-6,8-dioxaspiro[3,5]nona-5,9-di-one
(4S,5S,7R,12R)-SALVIANDULINE-B
| Title | Journal or Book | Year |
|---|---|---|
| Hemifistularin 3: a degraded peptide or biogenetic precursor? Isolation from a sponge of the order verongida from the coral sea or generation from base treatment of 11-oxofistularin 3 | Journal of the Chemical Society, Perkin Transactions 1 | 1993 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.